Healthcare
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Wearable Health Solutions, Inc. (WHSI) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of -28.8%, EPS growth of +86.7%, a dividend yield of 0.0%. What stands out right now is revenue -28.8%, EPS +86.7%, free cash flow +59.2% with operating margin -307.9% and ROIC 283.3%. Valuation is more restrained than many high-expectation growth names at price/sales 0.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines WHSI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
WHSI
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
WHSI Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for WHSI and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$1.0M
-12.7% YoY
FY Net Income
-$132.3K
+70.8% YoY
Free Cash Flow
-$2.8K
+99.5% YoY
Revenue Growth
-28.8%
EPS Growth
+86.7%
Gross Margin
35.9%
Net Margin
-320.6%
Income statement
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 745K | 1M | 1M | 1M | 1M |
| Gross Profit | 268K | 477K | 525K | 693K | 769K |
| Operating Income | -2M | -13M | -3M | -496K | -42K |
| EBITDA | -2M | -13M | -3M | -1M | -427K |
| Net Income | -2M | -13M | -3M | -454K | -132K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Cash & Equivalents | 136K | 71K | 847K | 0 | 60K |
| Total Assets | 223K | 339K | 908K | 644K | 292K |
| Total Liabilities | 4M | 2M | 4M | 3M | 2M |
| Shareholder Equity | -4M | -2M | -3M | -2M | -2M |
| Total Debt | 3M | 2M | 3M | 2M | 1M |
| Net Debt | 3M | 2M | 2M | 2M | 1M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
3K
+99.5% YoY
Capital Expenditures
0
Free Cash Flow
3K
+99.5% YoY
Key ratios
Gross Margin
35.9%
Operating Margin
-307.9%
Net Margin
-320.6%
ROE
84.3%
Debt / Equity
-0.77x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.